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Digestion of caldesmon with carboxypeptidase Y is accompanied by loss of its ability to inhibit actomyosin ATPase activ- 
ity and to bind actin and calmodulin. Similarly, carboxypeptidase Y digestion of a terminal 40 kDa chymotryptic frag- 
ment of caldesmon abolishes its inhibition of the actomyosin ATPase and binding to actin and calmodulin. This repre- 
sents the first direct demonstration that these functional domains of caldesmon are located close to the carboxy-terminus 
of the molecule. 
Actin; Calmodulin; Actin-binding protein; (Smooth muscle) 
1. INTRODUCTION 
Caldesmon is an actin- and calmodulin-binding 
protein present in smooth muscle and in a number 
of non-muscle cells [1,2]. Its binding to actin 
results in inhibition of the actin-activated ATPase 
activity of myosin; this inhibition can be blocked, 
at least partially, by calmodulin in the presence of 
Ca2+ [3-51 or by Ca2+/calmodulin-dependent 
phosphorylation of caldesmon [6,7]. These proper- 
ties of caldesmon suggest hat it may be involved in 
regulating actin-myosin interaction in a variety of 
contractile systems. 
Electron micrographs of rotary-shadowed cal- 
desmon reveal a flexible, extended morphology 
[8,9]. Sedimentation velocity measurements in- 
dicate a length of 740 A [lo]. To localize the actin- 
and calmodulin-binding domains on the caldesmon 
molecule, limited proteolysis with chymotrypsin 
combined with calmodulin affinity chromatogra- 
phy and sedimentation experiments have been 
exploited [ 11,121. All these biochemical activities 
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of caldesmon, i.e. its ability to bind actin and 
calmodulin and to inhibit actomyosin ATPase ac- 
tivity, are retained in a small fragment of 18 kDa 
[ 111. This fragment is derived from a larger one of 
40 kDa which appears early during proteolysis 
[ 1 l-141. The 40 kDa fragment of caldesmon has 
been tentatively placed at the C-terminus [12,15]. 
Here, we present direct evidence that the F-actin- 
and calmodulin-binding domains of caldesmon are 
located near the C-terminus of the caldesmon 
molecule. 
2. MATERIALS AND METHODS 
2.1. Preparation of proteins 
Caldesmon was prepared from fresh chicken gizzards ac- 
cording to Bretscher [ 161, Chymotryptic fragmentation and 
isolation of the 40 kDa fragment were performed as described 
[ll]. The 18 kDa chymotryptic fragment of caldesmon was 
prepared as in [l I] and further purified by extraction of the pep- 
tide from polyacrylamide gels after electrophoresis according to 
Laemmli [17] or by calmodulin-Sepharose affinity 
chromatography and CM-Sephadex cation-exchange 
chromatography. Removal of SDS from the gel-purified peptide 
was performed as described in [18]. Rabbit skeletal muscle 
myosin was prepared according to Perry [19] and further 
purified following the procedure of Kielley and Bradley [20]. 
Rabbit skeletal muscle actin and chicken gizzard tropomyosin 
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were prepared according to (211. The purity of all these proteins 
was checked by SDS-polyacrylamide gel electrophoresis. 
2.2. Protein cleavage 
Digestion of caldesmon or its 40 kDa fragment with carbox- 
ypeptidase Y was performed at a protein concentration of ap- 
prox. 1 mg/ml, at a 1: 10 (w/w) ratio of enzyme to substrate in 
75 mM KCI, 20 mM imidazole-HCl (pH 7.0), 1 mM 
2-mercaptoethanol, 10 mM NaNs at 30°C. The reaction was ter- 
minated by boiling of the withdrawn aliquots. Digestion of 
caldesmon with cu-chymotrypsin to produce 40 and 18 kDa 
fragments was performed at 30°C at an enzyme/substrate (w/w) 
ratio of 1: 1000 for the time giving the maximal yield of required 
fragment (usually 2 min for the 40 kDa peptide and 10 min for 
that of 18 kDa). For analytical purposes, a lower concentration 
of enzyme was also used as indicated in the figure legends. The 
reaction, performed in the same buffer as used for carboxypep- 
tidase Y cleavage, was stopped by addition of phenylmethane- 
sulfonyl fluoride (10 x the weight of chymotrypsin). 
2.3. A TPase assay 
ATPase activity of rabbit skeletal muscle actomyosin 
(reconstituted from 30 pg/ml F-actin and 120 pg/ml myosin) 
was assayed in the absence or presence of chicken gizzard 
tropomyosin (at a 1: 7 molar ratio to actin monomer) and intact 
or digested caldesmon or 40 kDa fragment in 50 mM KCl, 10 
mM imidazole-HCl (pH 7.0), 2 mM MgCls, 2 mM ATP, 0.1 
mM EGTA at 3O’C. The amount of Pi liberated was determined 
as in [22]. 
2.4. Amino acid analysis 
Triplicate samples of the 18 kDa chymotryptic fragment of 
caldesmon, purified by the two methods indicated in section 2.1, 
were dialyzed overnight against 2 x 10 1 of 10 mM N&HC03 
and hydrolyzed in vacua at 110°C in 6 N HCl containing 0.1% 
(w/v) phenol and 0.02% (v/v) 2-mercaptoethanol f r 24,48 and 
72 h prior to composition analysis by ninhydrin detection using 
a Beckman model 6300 amino acid analyzer equipped with a 
Spectra-Physics SP4270 2-channel integrator. 
2.5. Polyacrylamide gel electrophoresis 
SDS-polyacrylamide gel electrophoresis was carried out in 
7-20% gradient slab gels according to Laemmli 1171. For 
calculation of molecular mass, the following marker proteins 
were used: rabbit skeletal muscle myosin heavy chain (205 kDa), 
phosphorylase b (94 kDa), bovine serum albumin (66 kDa), ac- 
tin (42 kDa), troponin I (21 kDa) and calmodulin (16.7 kDa). 
2.6. Protein determination 
Protein concentration was determined by measuring UV light 
absorbance using the following values of extinction coefficients 
and molecular mass: caldesmon, El76 = 0.30, 140 kDa (161; G- 
actin, E~w =0.63, 42 kDa [23]; myosin, E~7~=0.54, 470 kDa 
[24]; chicken gizzard tropomyosin, Ez7s = 0.22, 72 kDa [25]; or 
by the method of Lowry et al. [26]. 
3. RESULTS AND DISCUSSION 
As shown in fig.lc, during chymotryptic treat- 
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Fig. 1. SDS-polyacrylamide gel electrophoresis of intact 
caldesmon (a), caldesmon digested with carboxypeptidase Y (b), 
caldesmon digested with cu-chymotrypsin (c), and carboxypep- 
tidase Y-treated caldesmon digested with cy-chymotrypsin (d). 
Caldesmon (1 mg/ml) was digested with carboxypeptidase Y at 
an enzyme/substrate ratio of 1: 10 (w/w) for 180 min at 30°C. 
The digestion with cu-chymotrypsin was performed for 1 min 
under the same conditions but at a 1: 1000 (w/w) ratio of en- 
zyme to substrate. 
ment of caldesmon under very mild conditions (en- 
zyme/substrate: 1: 20 000, w/w), the 40 kDa frag- 
ment appears after 1 min digestion, in parallel with 
high molecular mass fragments of 110 and 80 kDa. 
Only the 40 kDa fragment retains the ability of 
native caldesmon to bind actin and calmodulin and 
inhibit actomyosin ATPase activity [ 111. This sug- 
gests that the 40 kDa fragment originates from a 
terminal part of the caldesmon molecule. On the 
other hand, this fragment is not formed when 
caldesmon is first treated with carboxypeptidase Y 
and then with chymotrypsin (fig. 1 ,d), suggesting 
that it is the C-terminal peptide. 
Studying the effect of carboxypeptidase Y on 
caldesmon, we have found that degradation of this 
protein to 115 kDa and lower molecular mass 
fragments is accompanied by a gradual decrease of 
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Fig.2. Effect of carboxypeptidase Y-treated caldesmon on the 
ATPase activity of rabbit skeletal muscle actomyosin in the 
absence (0) and presence (0) of chicken gizzard tropomyosin. 
Molar ratio of caldesmon to actin monomer was 1: 10. Control 
ATPase activity of actomyosin in the absence of caldesmon was 
0.38 pmol Pi’mg myosin-’ .min-’ in the absence of tropo- 
myosin and 0.61 pmol Pi. mg myosin-’ . min-’ in the presence 
of tropomyosin. SDS-polyacrylamide gel electrophoresis shows 
the time course of digestion of caldesmon with carboxypep- 
tidase Y at a 1: 10 (w/w) enzyme/substrate ratio. 
its ability to inhibit actomyosin ATPase. The in- 
hibition is completely abolished in both the 
presence and absence of tropomyosin after disap- 
pearance of the parent caldesmon molecule (fig.2). 
Following digestion in the presence of tropomyo- 
sin, actomyosin ATPase activity is actually sig- 
nificantly (approx. 20%) above the control value. 
Degradation products bind neither to F-actin in 
sedimentation experiments nor to an affinity col- 
umn of calmodulin-Sepharose 4B (not shown). 
Moreover, carboxypeptidase Y treatment of the 
40 kDa fragment of caldesmon caused its degrada- 
tion to a 20 kDa polypeptide which again was inac- 
tive with respect to the inhibition of actomyosin 
ATPase (fig.3), as well as to the binding to actin 
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Fig.3. The effect of carboxypeptidase Y-treated 40 kDa chymo- 
tryptic fragment of caldesmon on the ATPase activity of rabbit 
skeletal muscle actomyosin in the absence (0) and presence (0) 
of chicken gizzard tropomyosin. Molar ratio of 40 kDa frag- 
ment of caldesmon to actin monomer was 1: 10. Control AT- 
Pase activities of actomyosin in the absence and presence of 
tropomyosin are given in the legend to fig.2. SDS-polyacryl- 
amide gel electrophoresis shows the time course of digestion of 
the 40 kDa fragment of caldesmon with carboxypeptidase Y at 
a 1: 10 (w/w) enzyme/substrate ratio. 
and calmodulin (not shown). Since caldesmon 
devoid of the 20 kDa C-terminal region loses actin- 
and calmodulin-binding properties and actomyosin 
ATPase inhibition, it can be concluded that these 
functional domains are located in this fragment. 
Prolonged digestion of caldesmon with cy- 
chymotrypsin results in degradation of the 40 kDa 
peptide to an 18 kDa fragment [l I-131. The amino 
acid composition of this peptide, purified by two 
different methods, is listed in table 1. It is a basic 
peptide at pH 7.5. Elucidation of the complete 
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Table 1 
Amino acid composition of the 18 kDa caldesmon fragment 
Amino acid Residues/m01 
ASP 
Thr 
Ser 
Glu 
Por 
GlY 
Ala 
Val 
Met 
lle 
Leu 
Tyr 
His 
Lys 
Arg 
+ Asn 
+ Gln 
13.3 
9.2 
16.6 
23.8 
7.0 
17.1 
15.5 
9.0 
1.3 
4.0 
9.1 
0.8 
3.2 
0.8 
8.0 
4.9 
amino acid sequence of caldesmon will allow more 
precise definition of this peptide. 
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